·8 min read
Novo Nordisk Falls 7.65% on Its Own Investor Day: 2030 Targets, the 2032 Patent Cliff and a DKK 150 Billion Promise
Novo Nordisk shares fell 7.65% to DKK 260 after its Capital Markets Day: growth in line with big pharma, DKK 150bn pipeline by 2035, patent cliff in 2032.